Compounds > atorvastatin
Page last updated: 2024-08-24

atorvastatin and Skin Neoplasms

atorvastatin has been researched along with Skin Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Adalsteinsson, JA; Feng, H; Hu, C; Jonasson, JG; Kristjansson, AK; Muzumdar, S; Olafsdottir, GH; Ratner, D; Silverberg, JI; Tryggvadottir, L; Ungar, J; Waldman, R; Wu, R1
Andalib, S; Asadpoor, M; Doustar, Y; Garjani, A; Garjani, M; Khorrami, A; Maleki-Dizaji, N; Rezazadeh, H; Soraya, H; Ziaee, M1
Carranza, DC; Chen, IY; Collisson, EA; Kolodney, MS1
Bayle, P; Bazex, J; Chouini-Lalanne, N; D'Incan, M; Drugeon, C; Gadroy, A; Journe, F; Marguery, MC1
Dellavalle, RP; Drake, AL; Freeman, SR; Graber, M; Heilig, LF; McNealy, K; Schilling, LM1
Ranki, A1

Reviews

1 review(s) available for atorvastatin and Skin Neoplasms

ArticleYear
Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.
    Journal of the National Cancer Institute, 2006, Nov-01, Volume: 98, Issue:21

    Topics: Atorvastatin; Bezafibrate; Clofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Incidence; Lovastatin; Melanoma; Odds Ratio; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Reproducibility of Results; Simvastatin; Skin Neoplasms; United States

2006

Other Studies

5 other study(ies) available for atorvastatin and Skin Neoplasms

ArticleYear
Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland.
    Archives of dermatological research, 2022, Volume: 314, Issue:8

    Topics: Atorvastatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Case-Control Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iceland; Simvastatin; Skin Neoplasms

2022
Ambivalent effects of atorvastatin on angiogenesis, epidermal cell proliferation and tumorgenesis in animal models.
    Iranian biomedical journal, 2012, Volume: 16, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Atorvastatin; Cell Proliferation; Croton Oil; Epidermal Cells; Epidermis; Female; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Mice; Neovascularization, Pathologic; Pyrroles; Rats; Rats, Wistar; Skin Neoplasms

2012
Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells.
    The Journal of investigative dermatology, 2002, Volume: 119, Issue:5

    Topics: Animals; Anticholesteremic Agents; Atorvastatin; Biocompatible Materials; Cell Movement; Collagen; Drug Combinations; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Humans; Laminin; Melanoma; Neoplasm Invasiveness; Neoplasm Metastasis; Protein Prenylation; Protein Processing, Post-Translational; Proteoglycans; Pyrroles; rhoA GTP-Binding Protein; Signal Transduction; Skin Neoplasms; Transcription, Genetic; Tumor Cells, Cultured

2002
UV-B phototoxic effects induced by atorvastatin.
    Archives of dermatology, 2006, Volume: 142, Issue:8

    Topics: Anticholesteremic Agents; Atorvastatin; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Heptanoic Acids; Humans; Middle Aged; Pyrroles; Sezary Syndrome; Skin Neoplasms; Skin Tests; Ultraviolet Rays

2006
Bexarotene combination therapy for patients with Sézary syndrome.
    Dermatologic clinics, 2008, Volume: 26 Suppl 1

    Topics: Antineoplastic Agents; Atorvastatin; Bexarotene; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine

2008